250 related articles for article (PubMed ID: 19996068)
1. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity.
Siddiqui AH; Irani RA; Blackwell SC; Ramin SM; Kellems RE; Xia Y
Hypertension; 2010 Feb; 55(2):386-93. PubMed ID: 19996068
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia.
Siddiqui AH; Irani RA; Zhang W; Wang W; Blackwell SC; Kellems RE; Xia Y
Hypertension; 2013 Feb; 61(2):472-9. PubMed ID: 23283357
[TBL] [Abstract][Full Text] [Related]
3. Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia.
Stepan H; Faber R; Wessel N; Wallukat G; Schultheiss HP; Walther T
J Clin Endocrinol Metab; 2006 Jun; 91(6):2424-7. PubMed ID: 16569734
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy.
Aggarwal S; Sunderland N; Thornton C; Xu B; Hennessy A; Makris A
Am J Obstet Gynecol; 2017 Feb; 216(2):170.e1-170.e8. PubMed ID: 27793555
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling.
Irani RA; Zhang Y; Zhou CC; Blackwell SC; Hicks MJ; Ramin SM; Kellems RE; Xia Y
Hypertension; 2010 May; 55(5):1246-53. PubMed ID: 20351341
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.
Herse F; Verlohren S; Wenzel K; Pape J; Muller DN; Modrow S; Wallukat G; Luft FC; Redman CW; Dechend R
Hypertension; 2009 Feb; 53(2):393-8. PubMed ID: 19064815
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia.
Wang W; Irani RA; Zhang Y; Ramin SM; Blackwell SC; Tao L; Kellems RE; Xia Y
Hypertension; 2012 Sep; 60(3):712-21. PubMed ID: 22868393
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension.
Herse F; LaMarca B
Am J Reprod Immunol; 2013 Apr; 69(4):413-8. PubMed ID: 23279165
[TBL] [Abstract][Full Text] [Related]
9. AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats.
Cunningham MW; Castillo J; Ibrahim T; Cornelius DC; Campbell N; Amaral L; Vaka VR; Usry N; Williams JM; LaMarca B
Hypertension; 2018 May; 71(5):886-893. PubMed ID: 29555668
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia.
Zhou CC; Irani RA; Zhang Y; Blackwell SC; Mi T; Wen J; Shelat H; Geng YJ; Ramin SM; Kellems RE; Xia Y
Circulation; 2010 Jan; 121(3):436-44. PubMed ID: 20065159
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia.
Yang J; Li L; Shang JY; Cai L; Song L; Zhang SL; Li H; Li X; Lau WB; Ma XL; Liu HR
J Hypertens; 2015 May; 33(5):1046-56. PubMed ID: 25693057
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond.
Xia Y; Kellems RE
Circ Res; 2013 Jun; 113(1):78-87. PubMed ID: 23788505
[TBL] [Abstract][Full Text] [Related]
13. Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia.
LaMarca B; Parrish MR; Wallace K
Gend Med; 2012 Jun; 9(3):139-46. PubMed ID: 22498426
[TBL] [Abstract][Full Text] [Related]
14. The agonistic autoantibodies to the angiotensin II type 1 receptor in pregnancies complicated by hypertensive disorders.
Szpera-Gozdziewicz A; Gozdziewicz T; Wirstlein P; Wender-Ozegowska E; Breborowicz GH
J Matern Fetal Neonatal Med; 2019 Apr; 32(7):1219-1223. PubMed ID: 29092665
[No Abstract] [Full Text] [Related]
15. Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy.
Brewer J; Liu R; Lu Y; Scott J; Wallace K; Wallukat G; Moseley J; Herse F; Dechend R; Martin JN; Lamarca B
Hypertension; 2013 Nov; 62(5):886-92. PubMed ID: 24041954
[TBL] [Abstract][Full Text] [Related]
16. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.
Hubel CA; Wallukat G; Wolf M; Herse F; Rajakumar A; Roberts JM; Markovic N; Thadhani R; Luft FC; Dechend R
Hypertension; 2007 Mar; 49(3):612-7. PubMed ID: 17210828
[TBL] [Abstract][Full Text] [Related]
17. The Role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia.
Campbell N; LaMarca B; Cunningham MW
Curr Pharm Biotechnol; 2018; 19(10):781-785. PubMed ID: 30255752
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
[TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia.
LaMarca B; Wallace K; Granger J
Curr Opin Pharmacol; 2011 Apr; 11(2):175-9. PubMed ID: 21317038
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Novel Agonist-Like Autoantibody in Preeclamptic Patients.
Velloso EP; Pimentel RL; Braga JF; Cabral AC; Reis ZS; Bader M; Santos RA; Wallukat G
Am J Hypertens; 2016 Mar; 29(3):405-12. PubMed ID: 26158852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
